Tracking defects caused by brain tumor mutation yields insight to advance targeted therapy

St. Jude Children’s Research Hospital scientists show that mutations in the DDX3X gene lead to different molecular defects; findings will aid efforts to develop more individualized therapy of medulloblastoma. (Janet F. Partridge, PhD)
Source: St. Jude Children's Research Hospital - Category: Pediatrics Source Type: news